What Are The Symptoms And Treatment For Igg4 Deficiency?

IgG4-related disease (IgG4-RD) is a condition where the immune system builds up a specific type of antibody-producing cell in organs, causing swelling, thickening, or masses that can mimic cancer. Symptoms depend entirely on which organs are involved — the most common being swollen salivary or tear glands, an enlarged pancreas, or enlarged lymph nodes. Treatment usually starts with corticosteroids, which reduce inflammation in most people, followed by steroid-sparing medications for those who relapse or cannot tolerate steroids long term.

What Are The Symptoms And Treatment For IgG4 Deficiency?

First, a naming clarification that matters. The condition is called IgG4-related disease, not IgG4 deficiency. It is not a shortage of IgG4 antibodies. It is the opposite — an overgrowth of IgG4-producing immune cells that form inflammatory masses in one or more organs.

This distinction is not pedantic. A true antibody deficiency is a different category of illness treated with immunoglobulin replacement. IgG4-RD is treated by suppressing an overactive immune response. If you or a family member received a diagnosis framed as “IgG4 deficiency,” it is worth confirming exactly what the clinician meant.

Symptoms come in two patterns. Some people have one organ affected. Others have several at once. The disease can also appear in organs without causing obvious symptoms, which is why some cases are found during imaging done for another reason.

Which Organs Does IgG4-Related Disease Affect?

IgG4-RD can involve almost any organ, but a handful account for most cases. The pattern of involvement is what often tips clinicians toward the diagnosis.

• Salivary and tear glands. Painless swelling of the glands that produce saliva and tears. When the tear and salivary glands enlarge together, it produces the appearance historically called Mikulicz disease.
• Pancreas. A form of chronic pancreatitis that can cause abdominal pain, weight loss, and sometimes obstructive jaundice if the bile duct is compressed. It is one of the most studied organ manifestations.
• Bile ducts. Narrowing of the bile ducts that can look very similar to a bile duct cancer on imaging.
• Lymph nodes. Enlarged nodes, often in the chest, abdomen, or neck.
• Retroperitoneum. Thickened tissue behind the abdominal organs that can compress the ureters or major blood vessels.
• Kidneys. Inflammatory masses or kidney impairment.
• Orbit. Swelling around the eye that can cause bulging, dryness, or vision changes.
• Aorta and other large vessels. Vessel wall thickening that can lead to aneurysm formation.
• Thyroid, lungs, meninges, and prostate. Less common but documented.

Some people also have allergic symptoms such as asthma, eczema, or chronic sinus problems. Whether these reflect the same underlying process or simply coexist is an area researchers are still working through. The evidence here is not settled.

What Causes IgG4-Related Disease?

The cause is not known. This is one of the more honest statements in immunology — no single trigger, gene, or environmental exposure has been confirmed as the cause.

What is known is the mechanism. The disease involves an immune response in which certain T cells and antibody-producing B cells accumulate in tissues. The result is inflammation and a characteristic pattern of scarring called storiform fibrosis. IgG4-positive plasma cells are found in the affected tissue, which is how the disease got its name.

There is an important nuance here. IgG4 antibodies are not thought to be the direct cause of the damage. They appear to be a marker of the immune response rather than its weapon. This is why researchers have moved away from calling it an autoimmune disease in the classic sense, though some still use that framing.

Blood levels of IgG4 are often elevated in people with the disease. But an elevated IgG4 level alone does not make the diagnosis, and a normal level does not rule it out. A meaningful proportion of people with confirmed IgG4-RD have normal serum IgG4. The blood test supports the picture — it does not define it.

How Is IgG4-Related Disease Diagnosed?

There is no single test that confirms IgG4-RD. Diagnosis is built from several pieces of evidence together, which makes it genuinely challenging and often slow.

Clinicians typically weigh four things:

• Which organs show swelling, masses, or thickening on imaging.
• Whether the blood IgG4 level is elevated.
• What a biopsy of the affected tissue shows under the microscope.
• Whether other conditions — especially cancer — have been reasonably excluded.

The biopsy matters more than the blood test. The combination of dense immune cell infiltration, storiform fibrosis, and an increased number of IgG4-positive plasma cells in the tissue is the strongest evidence. International consensus criteria for diagnosis exist, and they place tissue findings at the center.

The most important thing diagnosis must do is rule out cancer. Pancreatic IgG4-RD can look like pancreatic cancer on scans. Bile duct involvement can look like cholangiocarcinoma. Lymph node involvement can resemble lymphoma. This is why biopsy is usually not optional.

Some people are diagnosed without a biopsy when a biopsy is not safely possible and the clinical and imaging picture is strongly consistent. This is a judgment call made by specialists, not a standard shortcut.

How Is IgG4-Related Disease Treated?

Glucocorticoids — steroid medications such as prednisone — are the first-line treatment. Most people respond, often within weeks. Organ swelling and symptoms typically improve, and blood markers fall.

The problem is relapse. A large share of people who taper off steroids see the disease return. That has pushed treatment toward combining steroids with other medications that allow the steroid dose to be lowered or stopped.

Medications used for this purpose include:

• Rituximab. A biologic that depletes B cells. It is used in people who do not respond adequately to steroids, who relapse, or who cannot tolerate long-term steroids. Evidence for its use has grown over the past decade.
• Azathioprine and mycophenolate mofetil. Older immunosuppressants sometimes used as steroid-sparing agents. The trial evidence supporting them is limited compared with rituximab.
• Methotrexate. Also used in some cases, with similarly limited formal trial data.

This is an area where clinical practice has moved ahead of large randomized trials. Some clinicians use these agents routinely; the strength of evidence varies by drug. Rituximab has the most supportive data of the non-steroid options.

Treatment duration is not standardized. Some people need months of therapy. Others need years. Some achieve sustained remission and stop treatment entirely. There is no reliable way to predict at the outset which path a given person will take.

What Is the Outlook for People With IgG4-Related Disease?

The outlook is generally favorable for most people, with important exceptions. IgG4-RD is rarely life-threatening on its own, and it usually responds to treatment.

The main risks come from what the inflammation does to organs over time. Uncontrolled disease can cause permanent damage — pancreatic insufficiency, kidney impairment, bile duct scarring, or aortic aneurysm. Early recognition and treatment reduce these risks.

There is also a documented association between IgG4-RD and an increased risk of certain cancers, including lymphoma and pancreatic cancer. The relationship is recognized but not fully understood. It is one more reason follow-up care matters even after symptoms improve.

Long-term monitoring typically involves periodic imaging and blood work. The goal is to catch relapse or organ damage before it becomes irreversible.

What Should You Do If You Suspect IgG4-Related Disease?

See a specialist. IgG4-RD is uncommon, and many general clinicians will see few or no cases in a career. Rheumatologists, gastroenterologists, and immunologists with experience in the disease are the right starting point, depending on which organs are involved.

Ask directly whether cancer has been ruled out. This is the single most important question, because the two can look identical on scans.

Ask whether a biopsy was done or is planned. If a biopsy was not done, ask why.

Ask what the treatment plan is and how long it is expected to last. Ask what happens if the first treatment does not work.

Be cautious with any product or supplement marketed for IgG4-related disease. No supplement has been shown to treat this condition. The disease requires medical management.